Lai Yi (莱意)莱意
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司
主要成分Active Ingredients
- 氟马西尼Fuma Xini
- 冰醋酸Bingcu Suan
药物知识说明
氟马西尼是一种在国家药监局注册认定的药品。该药品含有冰醋酸-d1407310等成分。
该药品关联的活性成分包括：冰醋酸Bingcu Suan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司。
您可以探索含有相同成分的其他药品：冰醋酸-d1407310成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 莱意) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 冰醋酸Bingcu Suan.
Manufacturers recorded for this product: 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司.
Explore other medicines containing the same ingredient: 冰醋酸 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 莱意Recorded Chinese name: 莱意
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 5ml：0.5mg5 mL:0.5 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10980149
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10980149
Manufacturer
Chinese legal name: 浙江奥托康制药集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10980149
生产企业
浙江奥托康制药集团股份有限公司(国产)
适应症
逆转全身麻醉手术后因使用苯二氮卓类药物所致的中枢镇静和催眠。
用法用量
首次剂量：在15秒内将氟马西尼0.2mg(2ml)静脉注射，60秒后唤醒病人。如达到目的，可不再用药。追加剂量：首次剂量后60秒钟，如不能唤醒病人，可追加0.1mg(1ml)，再等60秒，再唤醒。每次可追加0.1mg(1ml)，总量不超过1mg。
不良反应
少数病人在应用时，会出现恶心或呕吐，在快速注射氟马西尼后，会有焦虑、心悸、恐惧等不适感，一过性血压增高及心率增加，癫痫患者可出现抽搐发作。这些不良反应通常不需要特殊处理。
禁忌
1、对此药及安定类过敏者，有严重抗抑郁剂中毒症状者。
2、正应用苯二氮卓类药控制癫痫持续状态或颅内压者。
3、有严重抗抑郁剂中毒者。
注意事项
手术结束时，麻醉师请勿在周围肌肉松弛消退前注射氟马西尼。
贮藏
遮光，密闭保存
规格
5ml：0.5mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.